http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#Head http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#assertion http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#provenance http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#pubinfo http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#assertion http://purl.obolibrary.org/obo/DOID_9538 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9538 http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00188 http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association http://www.w3.org/2000/01/rdf-schema#label bortezomib for injection is a proteasome inhibitor indicated for treatment of patients with multiple myeloma 1 1 treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy 1 2 bortezomib for injection is indicated for the treatment of patients with multiple myeloma bortezomib for injection is indicated for the treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00188 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#provenance http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#pubinfo http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig http://purl.org/nanopub/x/hasSignature dtVLUtonn7+7acexedTXXSLtoYsUK9Jz/sFet/bztf+9YYOX63NGGYnwPr+Db/0pfoZh2UReGCDeUsXtjbZRbSgM29R7slawzbKMspCnYmw+mcRArPgD9Aaa2mgxGbS+RUBXx/Mn2cb4ZfReo9Z2DkGGjVlQiF3q/RFgpyDoFc4= http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://purl.org/dc/terms/created 2021-06-27T20:11:57.454+02:00 http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA_yuWGLcTeIOIqQJd7VFGb013jWm0UEp7zA_hhWmTIc8 https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs